{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:10:05Z","timestamp":1792138205955,"version":"4.4.0"},"reference-count":90,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Erling-Persson Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016669","name":"Sj\u00f6bergstiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023931","name":"Harry Perkins Institute of Medical Research","doi-asserted-by":"crossref","award":["start-up grants"],"award-info":[{"award-number":["start-up grants"]}],"id":[{"id":"10.13039\/501100023931","id-type":"DOI","asserted-by":"crossref"}]},{"name":"V\u00e4strag\u00f6taland Region","award":["ALF grant"],"award-info":[{"award-number":["ALF grant"]}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BioCARE","award":["strategic grants"],"award-info":[{"award-number":["strategic grants"]}]},{"name":"Lion\u2019s Cancerfond V\u00e4st"},{"DOI":"10.13039\/501100005009","name":"Assar Gabrielssons Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gustaf V Jubileumsklinikens forskningsfond"},{"name":"Wilhelm och Martina Lundgrens Vetenskapsfond"}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Uveal melanoma (UM) is a rare melanoma originating in the eye\u2019s uvea, with 50% of patients experiencing metastasis predominantly in the liver. In contrast to cutaneous melanoma, there is only a limited effectiveness of combined immune checkpoint therapies, and half of patients with uveal melanoma metastases succumb to disease within 2 years. This study aimed to provide a path toward enhancing immunotherapy efficacy by identifying and functionally validating tumor-reactive T cells in liver metastases of patients with UM. We employed single-cell RNA-seq of biopsies and tumor-infiltrating lymphocytes (TILs) to identify potential tumor-reactive T cells. Patient-derived xenograft (PDX) models of UM metastases were created from patients, and tumor sphere cultures were generated from these models for co-culture with autologous or MART1-specific HLA-matched allogenic TILs. Activated T cells were subjected to TCR-seq, and the TCRs were matched to those found in single-cell sequencing data from biopsies, expanded TILs, and in livers or spleens of PDX models injected with TILs. Our findings revealed that tumor-reactive T cells resided not only among activated and exhausted subsets of T cells, but also in a subset of cytotoxic effector cells. In conclusion, combining single-cell sequencing and functional analysis provides valuable insights into which T cells in UM may be useful for cell therapy amplification and marker selection.<\/jats:p>","DOI":"10.7554\/elife.91705","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T09:53:11Z","timestamp":1700128391000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.91705","source":"Crossref","is-referenced-by-count":3,"title":["Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases"],"prefix":"10.7554","volume":"12","author":[{"given":"Joakim W","family":"Karlsson","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02xz7d723","id-type":"ROR","asserted-by":"publisher"}],"name":"Harry Perkins Institute of Medical Research and University of Western Australia","place":["Perth, Australia"]},{"id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"publisher"}],"name":"Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Vasu R","family":"Sah","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"publisher"}],"name":"Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-0355","authenticated-orcid":true,"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"publisher"}],"name":"Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]},{"id":[{"id":"https:\/\/ror.org\/04vgqjj36","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Surgery, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]},{"id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"publisher"}],"name":"Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Irina","family":"Kuznetsova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02xz7d723","id-type":"ROR","asserted-by":"publisher"}],"name":"Harry Perkins Institute of Medical Research and University of Western Australia","place":["Perth, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Munir","family":"Iqba","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01dbmzx78","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomics WA, Telethon Kids Institute, Harry Perkins Institute of Medical Research and University of Western Australia","place":["Nedlands, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Samuel","family":"Alsen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"publisher"}],"name":"Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Sofia","family":"Stenqvist","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"publisher"}],"name":"Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-0618","authenticated-orcid":true,"given":"Alka","family":"Saxena","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01dbmzx78","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomics WA, Telethon Kids Institute, Harry Perkins Institute of Medical Research and University of Western Australia","place":["Nedlands, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Lars","family":"Ny","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"publisher"}],"name":"Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]},{"id":[{"id":"https:\/\/ror.org\/04vgqjj36","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Oncology, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Lisa M","family":"Nilsson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02xz7d723","id-type":"ROR","asserted-by":"publisher"}],"name":"Harry Perkins Institute of Medical Research and University of Western Australia","place":["Perth, Australia"]},{"id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"publisher"}],"name":"Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0346-6837","authenticated-orcid":true,"given":"Jonas A","family":"Nilsson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02xz7d723","id-type":"ROR","asserted-by":"publisher"}],"name":"Harry Perkins Institute of Medical Research and University of Western Australia","place":["Perth, Australia"]},{"id":[{"id":"https:\/\/ror.org\/01tm6cn81","id-type":"ROR","asserted-by":"publisher"}],"name":"Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1002\/cncr.30258","type":"journal-article","article-title":"Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies","volume":"122","author":"Algazi","year":"2016","journal-title":"Cancer"},{"key":"bib2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02296-7","type":"journal-article","article-title":"An integrated framework for quantifying immune-tumour interactions in a 3D co-culture model","volume":"4","author":"Al Hity","year":"2021","journal-title":"Communications Biology"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1245\/s10434-015-4982-5","type":"journal-article","article-title":"Long-Term follow-up evaluation of 68 Patients with uveal melanoma liver metastases treated with isolated hepatic perfusion","volume":"23","author":"Ben-Shabat","year":"2016","journal-title":"Annals of Surgical Oncology"},{"key":"bib4","type":"software","article-title":"EnhancedVolcano","volume-title":"GitHub","author":"Blighe","year":"2018","unstructured":"Blighe K. 2018. EnhancedVolcano. GitHub. v.1.20.0. https:\/\/github.com\/kevinblighe\/EnhancedVolcano."},{"key":"bib5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/cam4.133","type":"journal-article","article-title":"Systemic treatment of metastatic uveal melanoma: Review of literature and future perspectives","volume":"2","author":"Buder","year":"2013","journal-title":"Cancer Medicine"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jhep.2021.12.036","type":"journal-article","article-title":"Liver stromal cells restrict macrophage maturation and stromal IL-6 limits the differentiation of cirrhosis-linked macrophages","volume":"76","author":"Buonomo","year":"2022","journal-title":"Journal of Hepatology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000370154","type":"journal-article","article-title":"Uveal melanoma patient-derived xenografts","volume":"1","author":"Carita","year":"2015","journal-title":"Ocular Oncology and Pathology"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","type":"journal-article","article-title":"Metastatic disease from uveal melanoma: treatment options and future prospects","volume":"101","author":"Carvajal","year":"2017","journal-title":"The British Journal of Ophthalmology"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S1470-2045(17)30251-6","type":"journal-article","article-title":"Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: A single-centre, two-stage, single-arm, phase 2 study","volume":"18","author":"Chandran","year":"2017","journal-title":"The Lancet. Oncology"},{"key":"bib10","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-00872-8","type":"journal-article","article-title":"XenoCell: Classification of cellular barcodes in single cell experiments from xenograft samples","volume":"14","author":"Cheloni","year":"2021","journal-title":"BMC Medical Genomics"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640725","type":"journal-article","article-title":"TCRMatch: Predicting T-cell receptor specificity based on sequence similarity to previously characterized receptors","volume":"12","author":"Chronister","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1084\/jem.20190249","type":"journal-article","article-title":"Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer","volume":"216","author":"Clarke","year":"2019","journal-title":"The Journal of Experimental Medicine"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.4049\/jimmunol.180.8.5327","type":"journal-article","article-title":"Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity","volume":"180","author":"Cl\u00e9menceau","year":"2008","journal-title":"Journal of Immunology"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","type":"journal-article","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"i172","DOI":"10.1093\/bioinformatics\/bts236","type":"journal-article","article-title":"Xenome--a tool for classifying reads from xenograft samples","volume":"28","author":"Conway","year":"2012","journal-title":"Bioinformatics"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","type":"journal-article","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Current Opinion in Immunology"},{"key":"bib17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116738119","type":"journal-article","article-title":"Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors","volume":"119","author":"\u00c7uburu","year":"2022","journal-title":"PNAS"},{"key":"bib18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070971","type":"journal-article","article-title":"Tebentafusp: T cell redirection for the treatment of metastatic uveal melanoma","volume":"11","author":"Damato","year":"2019","journal-title":"Cancers"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","type":"journal-article","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"bib20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05072-0","type":"journal-article","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nature Communications"},{"key":"bib21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14256-1","type":"journal-article","article-title":"Single-cell analysis reveals new evolutionary complexity in uveal melanoma","volume":"11","author":"Durante","year":"2020","journal-title":"Nature Communications"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"9609","DOI":"10.18632\/oncotarget.2445","type":"journal-article","article-title":"Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions","volume":"5","author":"Einarsdottir","year":"2014","journal-title":"Oncotarget"},{"key":"bib23","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.7116979","type":"software","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume-title":"Zenodo","author":"Ewels","year":"2022","unstructured":"Ewels P. 2022. The nf-core framework for community-curated bioinformatics pipelines. Zenodo. 0.1. https:\/\/doi.org\/10.5281\/zenodo.7116979."},{"key":"bib24","doi-asserted-by":"publisher","DOI":"10.1101\/791699","type":"preprint","article-title":"Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender","volume-title":"bioRxiv","author":"Fleming","year":"2022"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1158\/0008-5472.CAN-18-3158","type":"journal-article","article-title":"HER2 CAR-T Cells eradicate uveal melanoma and T-cell therapy-resistant human melanoma in IL2 transgenic NOD\/SCID IL2 receptor knockout mice","volume":"79","author":"Forsberg","year":"2019","journal-title":"Cancer Research"},{"key":"bib26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133094","type":"journal-article","article-title":"Recent advances and challenges in uveal melanoma immunotherapy","volume":"14","author":"Fu","year":"2022","journal-title":"Cancers"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ni.3775","type":"journal-article","article-title":"Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer","volume":"18","author":"Ganesan","year":"2017","journal-title":"Nature Immunology"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","type":"journal-article","article-title":"The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis","volume":"45","author":"Gerlach","year":"2016","journal-title":"Immunity"},{"key":"bib29","type":"software","article-title":"scDblFinder","volume-title":"BioConductor","author":"Germain","year":"2024","unstructured":"Germain PL. 2024. scDblFinder. BioConductor. 1.18.0. https:\/\/bioconductor.org\/packages\/release\/bioc\/vignettes\/scDblFinder\/inst\/doc\/scDblFinder.html."},{"key":"bib30","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02417-2","type":"journal-article","article-title":"3D tumor spheroid microarray for high-throughput, high-content natural killer cell-mediated cytotoxicity","volume":"4","author":"Gopal","year":"2021","journal-title":"Communications Biology"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1093\/bioinformatics\/btz517","type":"journal-article","article-title":"TCR3d: The T cell receptor structural repertoire database","volume":"35","author":"Gowthaman","year":"2019","journal-title":"Bioinformatics"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/JCI73639","type":"journal-article","article-title":"PD-1 identifies the patient-specific CD8","volume":"124","author":"Gros","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nbt.4091","type":"journal-article","article-title":"Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors","volume":"36","author":"Haghverdi","year":"2018","journal-title":"Nature Biotechnology"},{"key":"bib34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009290","type":"journal-article","article-title":"miQC: An adaptive probabilistic framework for quality control of single-cell RNA-sequencing data","volume":"17","author":"Hippen","year":"2021","journal-title":"PLOS Computational Biology"},{"key":"bib35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200348119","type":"journal-article","article-title":"Immune checkpoint inhibitors unleash pathogenic immune responses against the microbiota","volume":"119","author":"Hu","year":"2022","journal-title":"PNAS"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","type":"journal-article","article-title":"Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening","volume":"38","author":"Huang","year":"2020","journal-title":"Nature Biotechnology"},{"key":"bib37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33720-z","type":"journal-article","article-title":"Evolution and modulation of antigen-specific T cell responses in melanoma patients","volume":"13","author":"Huuhtanen","year":"2022","journal-title":"Nature Communications"},{"key":"bib38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI164809","type":"journal-article","article-title":"Single-cell characterization of anti-LAG3+anti-PD1 treatment in melanoma patients","volume":"1","author":"Huuhtanen","year":"2023","journal-title":"The Journal of Clinical Investigation"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/CJI.0b013e3181fad2b0","type":"journal-article","article-title":"Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells","volume":"33","author":"Inozume","year":"2010","journal-title":"Journal of Immunotherapy"},{"key":"bib40","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0158-0","type":"journal-article","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nature Reviews. Disease Primers"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00786-z","type":"journal-article","article-title":"Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model","volume":"8","author":"Jespersen","year":"2017","journal-title":"Nature Communications"},{"key":"bib42","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5623-3","type":"journal-article","article-title":"Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study","volume":"19","author":"Jespersen","year":"2019","journal-title":"BMC Cancer"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.6004\/jnccn.2018.7070","type":"journal-article","article-title":"Response to Anti-PD-1 in uveal melanoma without high-volume liver metastasis","volume":"17","author":"Johnson","year":"2019","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"bib44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15606-0","type":"journal-article","article-title":"Molecular profiling of driver events in metastatic uveal melanoma","volume":"11","author":"Karlsson","year":"2020","journal-title":"Nature Communications"},{"key":"bib45","type":"software","article-title":"Xenocell_nextflow","volume-title":"Software Heritage","author":"Karlsson","year":"2022","unstructured":"Karlsson J. 2022. Xenocell_nextflow. Software Heritage. swh:1:rev:bdf2a305d8482a7ba5d9ffaf173a6823f78f8eaa. https:\/\/archive.softwareheritage.org\/swh:1:dir:f5b2ae98e976d8491223e3fe9a90319e73d6f5c2;origin=https:\/\/github.com\/jowkar\/xenocell_nextflow;visit=swh:1:snp:cf8e682450fb736fd559e1adbc1e4a9dce518e1b;anchor=swh:1:rev:bdf2a305d8482a7ba5d9ffaf173a6823f78f8eaa."},{"key":"bib46","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/annonc\/mdz176","type":"journal-article","article-title":"Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study","volume":"30","author":"Khoja","year":"2019","journal-title":"Annals of Oncology"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","type":"journal-article","article-title":"Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"bib48","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a006111","type":"journal-article","article-title":"Intra- and intertumoral heterogeneity of liver metastases in a patient with uveal melanoma revealed by single-cell RNA sequencing","volume":"7","author":"Lin","year":"2021","journal-title":"Cold Spring Harbor Molecular Case Studies"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","type":"journal-article","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biology"},{"key":"bib50","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02596-y","type":"journal-article","article-title":"Patient-derived xenograft culture-transplant system for investigation of human breast cancer metastasis","volume":"4","author":"Ma","year":"2021","journal-title":"Communications Biology"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.34067\/KID.0003842021","type":"journal-article","article-title":"Monocytes and Macrophages in kidney transplantation and insights from single cell RNA-seq studies","volume":"2","author":"Malone","year":"2021","journal-title":"Kidney360"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-20-1247","type":"journal-article","article-title":"Tebentafusp, A TCR\/Anti-CD3 bispecific fusion protein targeting gp100, potently activated antitumor immune responses in patients with metastatic melanoma","volume":"26","author":"Middleton","year":"2020","journal-title":"Clinical Cancer Research"},{"key":"bib53","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000331","type":"journal-article","article-title":"Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study","volume":"8","author":"Najjar","year":"2020","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","type":"journal-article","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"The New England Journal of Medicine"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.gastha.2022.07.006","type":"journal-article","article-title":"Genetics and therapeutic responses to tumor-infiltrating lymphocyte therapy of pancreatic cancer patient-derived xenograft models","volume":"1","author":"Nilsson","year":"2022","journal-title":"Gastro Hep Advances"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.annonc.2019.11.002","type":"journal-article","article-title":"Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models","volume":"31","author":"Ny","year":"2020","journal-title":"Annals of Oncology"},{"key":"bib57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25332-w","type":"journal-article","article-title":"The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma","volume":"12","author":"Ny","year":"2021","journal-title":"Nature Communications"},{"key":"bib58","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-317","type":"journal-article","article-title":"Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial","volume":"15","author":"Olofsson","year":"2014","journal-title":"Trials"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1200\/JCO.22.01705","type":"journal-article","article-title":"Isolated hepatic perfusion with melphalan for patients with isolated uveal melanoma liver metastases: A multicenter, randomized, open-label, phase III trial (the SCANDIUM Trial)","volume":"41","author":"Olofsson Bagge","year":"2023","journal-title":"Journal of Clinical Oncology"},{"key":"bib60","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006255","type":"journal-article","article-title":"Survival and Quality of Life after Isolated Hepatic Perfusion with Melphalan as a Treatment for Uveal Melanoma Liver Metastases - Final Results from the Phase III Randomized Controlled Trial SCANDIUM","author":"Olofsson Bagge","year":"2024","journal-title":"Annals of Surgery"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/s41418-020-00730-7","type":"journal-article","article-title":"Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease","volume":"28","author":"Pandiani","year":"2021","journal-title":"Cell Death and Differentiation"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ccell.2021.01.011","type":"journal-article","article-title":"Melanoma models for the next generation of therapies","volume":"39","author":"Patton","year":"2021","journal-title":"Cancer Cell"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1200\/JCO.20.00605","type":"journal-article","article-title":"Nivolumab and ipilimumab in metastatic uveal melanoma: Results From a single-arm phase II study","volume":"39","author":"Pelster","year":"2021","journal-title":"Journal of Clinical Oncology"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1200\/JCO.20.00550","type":"journal-article","article-title":"Nivolumab plus ipilimumab for treatment-na\u00efve metastatic uveal melanoma: An open-label, multicenter, phase II trial by the Spanish multidisciplinary melanoma group (GEM-1402)","volume":"39","author":"Piulats","year":"2021","journal-title":"Journal of Clinical Oncology"},{"key":"bib65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08534-1","type":"journal-article","article-title":"Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy","volume":"10","author":"Rosato","year":"2019","journal-title":"Nature Communications"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1158\/1078-0432.CCR-15-2294","type":"journal-article","article-title":"Identification of an immunogenic subset of metastatic uveal melanoma","volume":"22","author":"Rothermel","year":"2016","journal-title":"Clinical Cancer Research"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","type":"journal-article","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nature Biotechnology"},{"key":"bib68","type":"software","article-title":"Seurat","volume-title":"Satija Lab","author":"Satija","year":"2024","unstructured":"Satija R. 2024. Seurat. Satija Lab. v5. https:\/\/satijalab.org\/seurat\/."},{"key":"bib69","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1002\/eji.200838516","type":"journal-article","article-title":"FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia","volume":"38","author":"Schreeder","year":"2008","journal-title":"European Journal of Immunology"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00002371-200205000-00008","type":"journal-article","article-title":"Frequency of MART-1\/MelanA and gp100\/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes","volume":"25","author":"Seiter","year":"2002","journal-title":"Journal of Immunotherapy"},{"key":"bib71","type":"software","article-title":"djvdj","volume-title":"GitHub","author":"Sheridan","year":"2020","unstructured":"Sheridan R. 2020. djvdj. GitHub. v0.0.0.9000. https:\/\/github.com\/rnabioco\/djvdj."},{"key":"bib72","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gkx760","type":"journal-article","article-title":"VDJdb: a curated database of T-cell receptor sequences with known antigen specificity","volume":"46","author":"Shugay","year":"2018","journal-title":"Nucleic Acids Research"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","type":"journal-article","article-title":"Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"bib74","type":"software","article-title":"ggsankey","volume-title":"GitHub","author":"Sjoberg","year":"2021","unstructured":"Sjoberg D. 2021. ggsankey. GitHub. v.0.0.99999. https:\/\/github.com\/davidsjoberg\/ggsankey."},{"key":"bib75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25960-2","type":"journal-article","article-title":"Confronting false discoveries in single-cell differential expression","volume":"12","author":"Squair","year":"2021","journal-title":"Nature Communications"},{"key":"bib76","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02377-x","type":"journal-article","article-title":"Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma","volume":"18","author":"Sugase","year":"2020","journal-title":"Journal of Translational Medicine"},{"key":"bib77","type":"software","article-title":"InferCNV of the trinity CTAT project. preprint at","volume-title":"Github","author":"Tickle","year":"2019","unstructured":"Tickle T, Tirosh I, Georgescu C, Brown M, Haas B. 2019. InferCNV of the trinity CTAT project. preprint at. Github. 124eec0. https:\/\/github.com\/broadinstitute\/inferCNV."},{"key":"bib78","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1093\/bioinformatics\/btx286","type":"journal-article","article-title":"McPAS-TCR: A manually curated catalogue of pathology-associated T cell receptor sequences","volume":"33","author":"Tickotsky","year":"2017","journal-title":"Bioinformatics"},{"key":"bib79","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000848","type":"journal-article","article-title":"Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up","volume":"8","author":"van den Berg","year":"2020","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"bib80","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060845","type":"journal-article","article-title":"Uveal versus cutaneous melanoma; same origin, very distinct tumor types","volume":"11","author":"van der Kooij","year":"2019","journal-title":"Cancers"},{"key":"bib81","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","type":"journal-article","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"bib82","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ygyno.2010.05.016","type":"journal-article","article-title":"Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE\/beta7 Integrin) in high-grade serous ovarian cancer","volume":"118","author":"Webb","year":"2010","journal-title":"Gynecologic Oncology"},{"key":"bib83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","type":"journal-article","article-title":"Spherical cancer models in tumor biology","volume":"17","author":"Weiswald","year":"2015","journal-title":"Neoplasia"},{"key":"bib84","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1158\/1078-0432.CCR-13-0945","type":"journal-article","article-title":"CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor","volume":"20","author":"Ye","year":"2014","journal-title":"Clinical Cancer Research"},{"key":"bib85","doi-asserted-by":"publisher","first-page":"16168","DOI":"10.1073\/pnas.242600099","type":"journal-article","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"PNAS"},{"key":"bib86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103409","type":"journal-article","article-title":"Senescent T cells: a potential biomarker and target for cancer therapy","volume":"68","author":"Zhang","year":"2021","journal-title":"EBioMedicine"},{"key":"bib87","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","type":"journal-article","article-title":"Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment","volume":"17","author":"Zhao","year":"2020","journal-title":"Cellular & Molecular Immunology"},{"key":"bib88","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ccell.2022.03.005","type":"journal-article","article-title":"Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers","volume":"40","author":"Zheng","year":"2022","journal-title":"Cancer Cell"},{"key":"dataset1","type":"dataset","article-title":"Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases","volume-title":"NCBI BioProject","author":"Karlsson","year":"2024","unstructured":"Karlsson J, Sah VR, Bagge RO, Kuznetsova I, Iqbal M, Als\u00e9n S, Stenqvis S, Saxena A, Ny L, Nilsson LM. 2024. Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases. NCBI BioProject. https:\/\/www.ncbi.nlm.nih.gov\/bioproject\/PRJNA1135711. PRJNA1135711."},{"key":"dataset2","type":"dataset","article-title":"Sequencing of uveal melanoma metastases","volume-title":"European Genome-phenome Archive","author":"Joakim","year":"2020","unstructured":"Joakim K, Jonas AN. 2020. Sequencing of uveal melanoma metastases. European Genome-phenome Archive. https:\/\/ega-archive.org\/datasets\/EGAD00001006031. EGAD00001006031."}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/91705\/elife-91705-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/91705\/elife-91705-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/91705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:15:38Z","timestamp":1787566538000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/91705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":90,"alternative-id":["10.7554\/eLife.91705"],"URL":"https:\/\/doi.org\/10.7554\/elife.91705","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.16.540908","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2023.05.16.540908","asserted-by":"object"}],"references":[{"id-type":"accession","id":"EGAD00001006031","asserted-by":"subject"}],"is-same-as":[{"id-type":"doi","id":"10.7554\/eLife.91705.3","asserted-by":"subject"}],"is-version-of":[{"id-type":"doi","id":"10.7554\/eLife.91705.1","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.91705.2","asserted-by":"subject"}],"is-supplemented-by":[{"id-type":"accession","id":"PRJNA1135711","asserted-by":"subject"},{"id-type":"uri","id":"https:\/\/archive.softwareheritage.org\/swh:1:dir:f5b2ae98e976d8491223e3fe9a90319e73d6f5c2;origin=https:\/\/github.com\/jowkar\/xenocell_nextflow;visit=swh:1:snp:cf8e682450fb736fd559e1adbc1e4a9dce518e1b;anchor=swh:1:rev:bdf2a305d8482a7ba5d9ffaf173a6823f78f8eaa","asserted-by":"subject"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"RP91705"}}